171 related articles for article (PubMed ID: 23109454)
1. Evaluation of the C3435T polymorphism in the MDR1 gene in patients with hepatocellular carcinoma.
Baldissera VD; de Mattos AA; Coral GP; de Araujo FB; Marroni CA; de Mello Brandão AB; Ott Fontes PR; Schmidt Cerski CT; Hartmann AA; Kretzmann Filho NA
Ann Hepatol; 2012; 11(6):899-906. PubMed ID: 23109454
[TBL] [Abstract][Full Text] [Related]
2. MDR1 gene polymorphism correlated with pathological characteristics and prognosis in patients with primary hepatocellular carcinoma receiving interventional therapy.
Hu W; Huang S; Dong L; Yu C; Li C; Zhang J
Anticancer Drugs; 2019 Mar; 30(3):233-240. PubMed ID: 30779721
[TBL] [Abstract][Full Text] [Related]
3. C3435T polymorphism in the MDR1 gene affects the enterocyte expression level of CYP3A4 rather than Pgp in recipients of living-donor liver transplantation.
Goto M; Masuda S; Saito H; Uemoto S; Kiuchi T; Tanaka K; Inui K
Pharmacogenetics; 2002 Aug; 12(6):451-7. PubMed ID: 12172213
[TBL] [Abstract][Full Text] [Related]
4. MDR1 C3435T polymorphism in patients with breast cancer.
Turgut S; Yaren A; Kursunluoglu R; Turgut G
Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
[TBL] [Abstract][Full Text] [Related]
5. Association of the P-glycoprotein transporter MDR1(C3435T) polymorphism with the susceptibility to renal epithelial tumors.
Siegsmund M; Brinkmann U; Scháffeler E; Weirich G; Schwab M; Eichelbaum M; Fritz P; Burk O; Decker J; Alken P; Rothenpieler U; Kerb R; Hoffmeyer S; Brauch H
J Am Soc Nephrol; 2002 Jul; 13(7):1847-54. PubMed ID: 12089380
[TBL] [Abstract][Full Text] [Related]
6. MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity.
Ameyaw MM; Regateiro F; Li T; Liu X; Tariq M; Mobarek A; Thornton N; Folayan GO; Githang'a J; Indalo A; Ofori-Adjei D; Price-Evans DA; McLeod HL
Pharmacogenetics; 2001 Apr; 11(3):217-21. PubMed ID: 11337937
[TBL] [Abstract][Full Text] [Related]
7. MDR1 gene C3435T polymorphism in chronic hepatitis C patients.
Parsa Nahad M; Makvandi M; Teimoori A; Jalilian S; Kayedani GA; Mahmoodi S
Microb Pathog; 2018 Jan; 114():63-67. PubMed ID: 29155127
[TBL] [Abstract][Full Text] [Related]
8. Association of MDR1 gene polymorphisms with susceptibility to hepatocellular carcinoma in the Chinese population.
Ren YQ; Han JQ; Cao JB; Li SX; Fan GR
Asian Pac J Cancer Prev; 2012; 13(11):5451-4. PubMed ID: 23317199
[TBL] [Abstract][Full Text] [Related]
9. The MTHFR C677T mutation is not a risk factor recognized for HBV-related HCC in a population with a high prevalence of this genetic marker.
Jiao X; Luo Y; Yang B; Jing L; Li Y; Liu C; Jing X; Wang F; Wang Y; Du Z; Gao Y
Infect Genet Evol; 2017 Apr; 49():66-72. PubMed ID: 28082187
[TBL] [Abstract][Full Text] [Related]
10. Association between the c.1564A>T genetic polymorphism of the MDR1 gene and hepatocellular carcinoma in Chinese population.
Wan YY; Wang XW; Hui HX; Wan L
Genet Mol Res; 2014 Aug; 13(3):6820-6. PubMed ID: 25177961
[TBL] [Abstract][Full Text] [Related]
11. Association analysis between MDR1 gene polymorphisms and risk of hepatocellular carcinoma in Chinese population.
Yang D; Zhou F; Wang X; Gao H; Li G; Xue M
Biomarkers; 2013 May; 18(3):236-41. PubMed ID: 23488625
[TBL] [Abstract][Full Text] [Related]
12. Possible roles of the xenobiotic transporter P-glycoproteins encoded by the MDR1 3435 C>T gene polymorphism in differentiated thyroid cancers.
Ozdemir S; Uludag A; Silan F; Atik SY; Turgut B; Ozdemir O
Asian Pac J Cancer Prev; 2013; 14(5):3213-7. PubMed ID: 23803106
[TBL] [Abstract][Full Text] [Related]
13. Association between the c.3751G>a genetic variant of MDR1 and hepatocellular carcinoma risk in a Chinese Han population.
Li XF; He HB; Zhu YS; He JK; Ye WW; Chen YX; Lou LQ
Asian Pac J Cancer Prev; 2013; 14(9):5361-5. PubMed ID: 24175826
[TBL] [Abstract][Full Text] [Related]
14. Frequency of the C1236T, G2677T/A and C3435T MDR1 gene polymorphisms in the Serbian population.
Milojkovic M; Stojnev S; Jovanovic I; Ljubisavljevic S; Stefanovic V; Sunder-Plassman R
Pharmacol Rep; 2011; 63(3):808-14. PubMed ID: 21857092
[TBL] [Abstract][Full Text] [Related]
15. Study of ABCB1 polymorphism frequency in breast cancer patients from Poland.
Rubiś B; Hołysz H; Barczak W; Gryczka R; Łaciński M; Jagielski P; Czernikiewicz A; Półrolniczak A; Wojewoda A; Perz K; Białek P; Morze K; Kanduła Z; Lisiak N; Mrozikiewicz PM; Grodecka-Gazdecka S; Rybczyńska M
Pharmacol Rep; 2012; 64(6):1560-6. PubMed ID: 23406767
[TBL] [Abstract][Full Text] [Related]
16. Association of polymorphism in microRNA 604 with susceptibility to persistent hepatitis B virus infection and development of hepatocellular carcinoma.
Cheong JY; Shin HD; Cho SW; Kim YJ
J Korean Med Sci; 2014 Nov; 29(11):1523-7. PubMed ID: 25408584
[TBL] [Abstract][Full Text] [Related]
17. Expression of P-glycoprotein in hepatocellular carcinoma: a potential marker of prognosis.
Soini Y; Virkajärvi N; Raunio H; Pääkkö P
J Clin Pathol; 1996 Jun; 49(6):470-3. PubMed ID: 8763260
[TBL] [Abstract][Full Text] [Related]
18. The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells.
Hitzl M; Drescher S; van der Kuip H; Schäffeler E; Fischer J; Schwab M; Eichelbaum M; Fromm MF
Pharmacogenetics; 2001 Jun; 11(4):293-8. PubMed ID: 11434506
[TBL] [Abstract][Full Text] [Related]
19. Association of Single Nucleotide Polymorphism rs1053004 in Signal Transducer and Activator of Transcription 3 (STAT3) with Susceptibility to Hepatocellular Carcinoma in Thai Patients with Chronic Hepatitis B.
Chanthra N; Payungporn S; Chuaypen N; Pinjaroen N; Poovorawan Y; Tangkijvanich P
Asian Pac J Cancer Prev; 2015; 16(12):5069-73. PubMed ID: 26163643
[TBL] [Abstract][Full Text] [Related]
20. Detection of C1236T, G2677T/A, and C3435T polymorphism of MDR1 by amplification refractory mutation system PCR.
Chen B; Fang J; Zhang W; Jin Z; Yu Z; Cai W
J Clin Lab Anal; 2009; 23(2):110-6. PubMed ID: 19288456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
